MKI67 and breast cancer: Subsequently, immunohistochemical determination of hormone receptors expression, overexpression and/or amplification of human epidermal growth factor receptor 2 (ERBB2/HER2, OMIM:164870), and expression of proliferative marker Ki‐67 simplified the BC subtyping [3].